Biodexa Pharmaceuticals (Wales) Limited

Active04929486 Private limited company

Incorporated: 10 October 2003 (23 years)
Previously known as: Midatech Pharma (Wales) Limited (until 15 May 2023)
Q Chip Limited (until 23 January 2015)
Industry: Research and experimental development on biotechnology (72110)
Directors: Fiona Mary Powell
Stephen Anthony Stamp
Owned by: Biodexa Pharmaceuticals PLC
Accounts type: Full
Region: Wales
Address: 1 Caspian Point
Caspian Way
Cardiff
CF10 4DQ

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 3 December 2026
Last conf. stmt: 19 November 2025

Charges

Total: 8
Outstanding: 0
Part satisfied: 0
Satisfied: 8

Officers 3 active

Officer details are public data from the Companies House register.

Powell, Fiona Mary

Director · Appointed 14 January 2026

Also at Biodexa Pharmaceuticals PLC, Biodexa Ltd

British

Born September 1968 (58)

Stamp, Stephen

Secretary · Appointed 9 September 2019

Stamp, Stephen Anthony

Director · Appointed 9 September 2019

Also at Biodexa Pharmaceuticals PLC, Biodexa Ltd · more companies

British

Born November 1961

Officer history (29 former)

14 January 2026

Appointed Powell, Fiona Mary as Director

30 April 2020

Resigned Cook, Craig Richard, Dr as Director

9 September 2019

Resigned Robbins Cherry, Nicholas John as Director

9 September 2019

Appointed Stamp, Stephen as Secretary

9 September 2019

Appointed Stamp, Stephen Anthony as Director

9 September 2019

Resigned Robbins Cherry, Nicholas John as Secretary

1 June 2018

Appointed Cook, Craig Richard, Dr as Director

31 May 2018

Resigned Phillips, James Neil, Dr as Director

9 December 2014

Resigned Palmer, Daniel David, Dr as Director

8 December 2014

Resigned Sparey, Timothy Jason, Dr as Director

8 December 2014

Resigned Powell, Kenneth Leslie, Dr as Director

8 December 2014

Appointed Phillips, James Neil, Dr as Director

8 December 2014

Resigned Turton, Simon as Director

8 December 2014

Appointed Robbins Cherry, Nicholas John as Secretary

8 December 2014

Resigned Stv Nominee Ltd as Corporate Director

8 December 2014

Resigned Smith, Richard Ian as Director

8 December 2014

Appointed Robbins Cherry, Nicholas John as Director

8 December 2014

Resigned Jones, Michael as Secretary

16 September 2014

Resigned Limburg Ventures Bv as Corporate Director

24 March 2014

Resigned Altschuler, David Simon as Director

24 March 2014

Appointed Turton, Simon as Director

23 October 2013

Appointed Palmer, Daniel David, Dr as Director

5 September 2013

Appointed Altschuler, David Simon as Director

8 July 2013

Resigned Keen, Peter as Director

12 February 2013

Resigned Chanas, Alex as Director

19 November 2012

Appointed Sparey, Timothy Jason, Dr as Director

20 December 2011

Resigned Macpherson, Johanna Kate, Dr as Director

1 October 2011

Appointed Chanas, Alex as Director

15 September 2011

Appointed Limburg Ventures Bv as Corporate Director

1 July 2011

Appointed Keen, Peter as Director

6 August 2010

Resigned E-Synergy Nominees Limited as Corporate Director

6 August 2010

Resigned Griffiths, Dominic John Finbar, Dr as Director

14 October 2009

Appointed Smith, Richard Ian as Director

14 October 2009

Appointed E-Synergy Nominees Limited as Corporate Director

14 October 2009

Resigned Brook, Richard Anthony as Director

14 October 2009

Resigned Harrison, Richard Leslie as Director

30 September 2009

Resigned Barry, Mark Dafydd as Director

26 July 2009

Resigned Mitterrand, Maxime Fernand as Director

22 June 2009

Appointed Stv Nominee Ltd as Corporate Director

22 June 2009

Resigned De Boucaud, Cedriane Marie as Director

15 January 2008

Appointed Mitterrand, Maxime Fernand as Director

15 January 2008

Appointed De Boucaud, Cedriane Marie as Director

5 December 2007

Appointed Powell, Kenneth Leslie, Dr as Director

4 October 2007

Appointed Griffiths, Dominic John Finbar, Dr as Director

1 October 2007

Resigned Capital Law Secretaries Limited as Corporate Secretary

1 October 2007

Appointed Jones, Michael as Secretary

30 April 2007

Resigned Owen, David Andrew Arlwydd, Dr as Director

1 July 2006

Appointed Harrison, Richard Leslie as Director

22 May 2006

Resigned Curnock Cook, Jeremy Lawrence as Director

20 February 2006

Appointed Owen, David Andrew Arlwydd, Dr as Director

20 February 2006

Resigned Thewlis, David as Director

1 October 2004

Appointed Curnock Cook, Jeremy Lawrence as Director

11 May 2004

Appointed Brook, Richard Anthony as Director

4 December 2003

Appointed Thewlis, David as Director

10 October 2003

Resigned Severnside Nominees Limited as Corporate Nominee Director

10 October 2003

Appointed Capital Law Secretaries Limited as Corporate Secretary

10 October 2003

Appointed Severnside Nominees Limited as Corporate Nominee Director

10 October 2003

Appointed Barry, Mark Dafydd as Director

10 October 2003

Resigned Severnside Secretarial Limited as Corporate Nominee Secretary

10 October 2003

Appointed Macpherson, Johanna Kate, Dr as Director

10 October 2003

Appointed Severnside Secretarial Limited as Corporate Nominee Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Biodexa Pharmaceuticals PLC

Corporate entity · Notified 6 April 2016

Owns 75–100% of shares

Plc

Reg. no. 09216368

Group structure 4 companies

Ownership group derived from the Companies House PSC register

Biodexa Pharmaceuticals PLC

Biodexa Ltd Owns 75–100% of shares

Biodexa Pharmaceuticals (Wales) Limited This company Owns 75–100% of shares

Haaland UK Limited Owns 75–100% of shares

Filings

Recent filings only. See the full history on Companies House

Date	Description	Made Up To
24 April 2026	Full accounts	31 December 2025
5 February 2026	Appointment of a director
21 November 2025	Confirmation statement with no updates	19 November 2025
4 July 2025	Accounts for a small company	31 December 2024
20 November 2024	Confirmation statement with no updates	19 November 2024